255 related articles for article (PubMed ID: 17763162)
1. The influence of calcineurin inhibitors on pulse wave velocity in renal transplant recipients.
Strózecki P; Adamowicz A; Włodarczyk Z; Manitius J
Ren Fail; 2007; 29(6):679-84. PubMed ID: 17763162
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with increased arterial stiffness in renal transplant recipients.
Strózecki P; Adamowicz A; Włodarczyk Z; Manitius J
Med Sci Monit; 2010 Jun; 16(6):CR301-6. PubMed ID: 20512094
[TBL] [Abstract][Full Text] [Related]
3. Arterial elasticity measurement in renal transplant patients under anticalcineurin immunosuppression.
Martínez-Castelao A; Sarrias X; Bestard O; Gil-Vernet S; Serón D; Cruzado JM; Moreso F; Díez-Noguera A; Grinyó JM
Transplant Proc; 2005 Nov; 37(9):3788-90. PubMed ID: 16386539
[TBL] [Abstract][Full Text] [Related]
4. Pulse wave analysis to assess vascular compliance changes in stable renal transplant recipients.
Cohen DL; Warburton KM; Warren G; Bloom RD; Townsend RR
Am J Hypertens; 2004 Mar; 17(3):209-12. PubMed ID: 15001192
[TBL] [Abstract][Full Text] [Related]
5. Long graft cold ischemia time is associated with increased arterial stiffness in renal transplant recipients.
Strózecki P; Adamowicz A; Kozłowski M; Włodarczyk Z; Manitius J
Transplant Proc; 2009 Nov; 41(9):3580-4. PubMed ID: 19917348
[TBL] [Abstract][Full Text] [Related]
6. Calcineurin inhibitors and post-transplant weight gain.
Ersoy A; Baran B; Ersoy C; Kahvecioglu S; Akdag I
Nephrology (Carlton); 2008 Oct; 13(5):433-9. PubMed ID: 18331443
[TBL] [Abstract][Full Text] [Related]
7. Switch of immunosuppression from cyclosporine A to everolimus: impact on pulse wave velocity in stable de-novo renal allograft recipients.
Seckinger J; Sommerer C; Hinkel UP; Hoffmann O; Zeier M; Schwenger V
J Hypertens; 2008 Nov; 26(11):2213-9. PubMed ID: 18854763
[TBL] [Abstract][Full Text] [Related]
8. Associations between calcineurin inhibitors and arterial compliance in kidney transplant recipients.
Wystrychowski G; Chudek J; Zukowska-Szczechowska E; Wiecek A; Grzeszczak W
J Nephrol; 2008; 21(1):81-92. PubMed ID: 18264940
[TBL] [Abstract][Full Text] [Related]
9. Increased pulse wave velocity and shortened pulse wave propagation time in young patients with rheumatoid arthritis.
Yildiz M; Soy M; Kurum T; Ozbay G
Can J Cardiol; 2004 Sep; 20(11):1097-100. PubMed ID: 15457305
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of cyclosporine and tacrolimus on arterial function.
Seibert F; Behrendt C; Schmidt S; van der Giet M; Zidek W; Westhoff TH
Transpl Int; 2011 Jul; 24(7):708-15. PubMed ID: 21569126
[TBL] [Abstract][Full Text] [Related]
11. Increased pulse wave velocity and blood pressure in children who have undergone cardiac transplantation.
Klinge A; Allen J; Murray A; O'Sullivan J
J Heart Lung Transplant; 2009 Jan; 28(1):21-5. PubMed ID: 19134526
[TBL] [Abstract][Full Text] [Related]
12. Large artery stiffness and pulse wave reflection: results of a population-based study.
Filipovský J; Tichá M; Cífková R; Lánská V; Stastná V; Roucka P
Blood Press; 2005; 14(1):45-52. PubMed ID: 15823947
[TBL] [Abstract][Full Text] [Related]
13. Pulse wave velocity and coronary risk stratification.
Mendonça MI; Reis RP; Sousa AC; Gomes S; Faria P; Pereira A; Silva B; Serrão M; Santos N; Sousa FS; Silva JA; Sousa J; Ornelas I; Freitas S; Cardoso A; Araújo JJ
Rev Port Cardiol; 2009 Feb; 28(2):155-71. PubMed ID: 19438151
[TBL] [Abstract][Full Text] [Related]
14. Arterial stiffness in chronic renal failure and after renal transplantation.
Löcsey L; Szlanka B; Borbás B; Szabó L; Dán A; Asztalos L; Fedor R; Ménes I; Lörincz I
Transplant Proc; 2010; 42(6):2299-303. PubMed ID: 20692467
[TBL] [Abstract][Full Text] [Related]
15. Do blood pressure and arterial wall properties change after conversion from cyclosporine to tacrolimus?
Gelens MA; Christiaans MH; v Hooff JP
Transplant Proc; 2005 May; 37(4):1900-1. PubMed ID: 15919498
[TBL] [Abstract][Full Text] [Related]
16. Slowing the progression of chronic allograft nephropathy by conversion from cyclosporine to tacrolimus: a randomized controlled trial.
Meier M; Nitschke M; Weidtmann B; Jabs WJ; Wong W; Suefke S; Steinhoff J; Fricke L
Transplantation; 2006 Apr; 81(7):1035-40. PubMed ID: 16612281
[TBL] [Abstract][Full Text] [Related]
17. Effect of oral fructose load on serum uric acid and lipids in kidney transplant recipients treated with cyclosporine or tacrolimus.
Zawiasa A; Szklarek-Kubicka M; Fijałkowska-Morawska J; Nowak D; Rysz J; Mamełka B; Nowicki M
Transplant Proc; 2009; 41(1):188-91. PubMed ID: 19249511
[TBL] [Abstract][Full Text] [Related]
18. Lipid profiles in pediatric thoracic transplant recipients are determined by their immunosuppressive regimens.
Law YM; Yim R; Agatisa P; Boyle GJ; Miller SA; Lawrence K; Webber SA
J Heart Lung Transplant; 2006 Mar; 25(3):276-82. PubMed ID: 16507419
[TBL] [Abstract][Full Text] [Related]
19. Impact of calcineurin inhibitors on urinary excretion of mycophenolic acid and its glucuronide in kidney transplant recipients.
Naito T; Mino Y; Otsuka A; Ushiyama T; Ito T; Ozono S; Kagawa Y; Kawakami J
J Clin Pharmacol; 2009 Jun; 49(6):710-8. PubMed ID: 19451405
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome and age-related progression of aortic stiffness.
Safar ME; Thomas F; Blacher J; Nzietchueng R; Bureau JM; Pannier B; Benetos A
J Am Coll Cardiol; 2006 Jan; 47(1):72-5. PubMed ID: 16386667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
